|
|
|
|
|
|
|
|
press release
Intent-to-Treat Analysis Shows Statistically Significant Reduction in Tumour Burden as Measured by CA-125
Update Highlights
Response Using CA-125 Measurements by Treatment Among all Patients
CA-125 Response
|
Treatment
| ||
Paclitaxel
|
Paclitaxel+REOLYSIN®
|
Total
| |
Full Response
|
1 (1.85%)
|
5 (9.26%)
|
6
|
Partial Response
|
9 (16.67%)
|
7 (12.96%)
|
16
|
Stable Disease
|
3 (5.56%)
|
12 (22.22%)
|
15
|
Progressive Disease
|
0 (0.00%)
|
2 (3.70%)
|
2
|
Indeterminate
|
16 (29.63%)
|
13 (24.07%)
|
29
|
Not Evaluable
|
25 (46.30%)
|
15 (27.78%)
|
40
|
Total
|
54
|
54
|
108
|
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.